HIGH RISK LOCALIZED PROSTATE CANCER
Clinical trials for HIGH RISK LOCALIZED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK LOCALIZED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HIGH RISK LOCALIZED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo could cut hormone therapy time for prostate cancer patients
Disease control Not yet recruitingThis study tests whether adding a radioactive drug called 177Lu-PSMA-617 to standard radiation therapy can allow men with high-risk localized prostate cancer to take hormone therapy for only 6 months instead of the usual 24 months. The goal is to see if this approach is as effect…
Matched conditions: HIGH RISK LOCALIZED PROSTATE CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
700 men with prostate cancer to help shape future treatments
Knowledge-focused Not yet recruitingThis study will follow 700 men with high-risk localized or metastatic prostate cancer to collect detailed information on how they are treated in everyday practice. Researchers will track treatments, side effects, quality of life, and disease progression over time. The goal is to …
Matched conditions: HIGH RISK LOCALIZED PROSTATE CANCER
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC